Information will follow
The 8th meeting of LNIA and Anti-epilepsy asociation “Sleep and epilepsy” took place 17.02.2017. at Tallink Hotel Riga. The meeting was directed by Chairperson of the Board Doc. Viktorija Ķēniņa and Jurgis Strautmanis.
The 6th meeting of LNIA “Elevated KPK levels…” took place 16.12.2015. at Paul Stradins Clinical University Hospital. The meeting was directed by Chairperson of the Board Doc. Viktorija Ķēniņa.
The 4th meeting of LNIA togather with Latvian Society of Immunologists “Immunodeficiency in clinical practice” took place 06.03.15 at Islande Hotel Riga. The meeting was directed by Chairperson of the Board Asoc.prof. Simona Doniņa.
The second meeting of LNIA “Antiphospholipid syndrome” took place 18.10.13 at Maritim Park Hotel Riga. The meeting was directed by Chairperson of the Board Doc. Viktorija Ķēniņa.
The participants of this meeting could listen to asoc. prof. I Mihailova, doc. N. Kurjāne and dr. A. Kostik presentations about etiopathogenesis, most frequent manifestations, diagnostic and treatment strategies of antiphospholipid syndrome. Insight into homocysteinemia’s and homocystinuria’s etiology and their management strategies was provided by Doc. V. Ķēniņa.
More than 130 participants attended this meeting.
The first meeting of LNIA “Autoimmune polyneuropathies” took place at Islande Hotel in collaboration with Shire and Octopharma companies at 8th March of 2013. The meeting was chaired by LNIA president doc. Viktorija Ķēniņa.
The agenda of the day was: causes of autoimmune diseases and basic principles of diagnostics presented by asoc. prof. Inese Mihailova. The overview of the etiopathogenesis of frequent autoimmune disorders and clinical aspects was presented by dr. Anželika Gudreniece. Then the lecture about diagnostics and treatment options of autoimmune polyneuropathies was presented by doc. Viktorija Ķēniņa. In turn, mechanisms of action and indications of immunoglobulin therapy in neurology were explained in doc. Nataļja Kurjāne lecture.
180 doctors attended the meeting.